PortfoliosLab logoPortfoliosLab logo
ISIN
US92556V1061
CUSIP
001103120
IPO Date
Nov 16, 2020

Highlights

Market Cap
$18.08B
Enterprise Value
$32.55B
EPS (TTM)
-$0.25
Total Revenue (TTM)
$14.56B
Gross Profit (TTM)
$5.01B
EBITDA (TTM)
$1.89B
Year Range
$8.63 - $17.53
Target Price
$15.25
ROA (TTM)
-0.80%
ROE (TTM)
-2.02%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

VTRS Performance Chart

Viatris Inc. (VTRS) is up 25.5% since the beginning of the year. At $15 per share, VTRS is trading 12.3% below its 52-week high of $18. Investors who bought $1,000 worth of VTRS shares 5 years ago would now be looking at an investment worth $1,339.


Loading charts...

S&P 500 Index

Returns By Period

Viatris Inc. (VTRS) has returned 25.50% so far this year and 80.23% over the past 12 months.


Viatris Inc.

1D
0.07%
1M
-7.63%
YTD
25.50%
6M
30.10%
1Y
80.23%
3Y*
21.50%
5Y*
6.02%
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VTRS Monthly Returns History

Based on dividend-adjusted daily data since Nov 16, 2020, VTRS's average daily return is +0.04%, while the average monthly return is +0.77%. At this rate, an investment would double in approximately 7.5 years.

Historically, 47% of months were positive and 53% were negative. The best month was Aug 2025 with a return of +22.1%, while the worst month was Feb 2022 at -25.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.

On a daily basis, VTRS closed higher 49% of trading days. The best single day was Nov 7, 2024 with a return of +13.5%, while the worst single day was Feb 28, 2022 at -24.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20265.14%14.06%-8.74%10.58%9.63%-5.41%25.50%
2025-9.40%-18.17%-4.45%-3.33%5.89%1.59%-2.13%22.08%-6.16%4.65%4.38%16.46%5.08%
20248.68%5.10%-2.53%-3.10%-7.36%0.28%13.45%1.20%-3.89%-0.09%13.88%-4.89%19.68%
20239.25%-6.25%-14.66%-3.01%-0.67%9.07%5.51%3.20%-8.28%-9.74%4.48%17.97%2.06%
202210.64%-25.84%-1.18%-5.06%20.00%-14.67%-7.45%-0.29%-10.79%18.90%10.08%0.91%-14.29%
2021-9.34%-12.60%-5.93%-4.80%15.40%-6.23%-1.54%4.76%-7.38%-1.48%-7.01%9.91%-26.12%

Benchmark Metrics

Viatris Inc. has an annualized alpha of -2.14%, beta of 0.80, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since November 16, 2020.

  • This stock participated in 126.76% of S&P 500 Index downside but only 84.42% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-2.14%
Beta
0.80
0.15
Upside Capture
84.42%
Downside Capture
126.76%

Return for Risk

Risk / Return Rank

VTRS ranks 91 for risk / return — in the top 91% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


VTRS Risk / Return Rank: 9191
Overall Rank
VTRS Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
VTRS Sortino Ratio Rank: 9292
Sortino Ratio Rank
VTRS Omega Ratio Rank: 9191
Omega Ratio Rank
VTRS Calmar Ratio Rank: 9090
Calmar Ratio Rank
VTRS Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Viatris Inc. (VTRS) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VTRSBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+0.46

Sortino ratioReturn per unit of downside risk

+0.70

Omega ratioGain probability vs. loss probability

1.43

1.37

+0.06

Calmar ratioReturn relative to maximum drawdown

4.25

2.78

+1.47

Martin ratioReturn relative to average drawdown

11.93

12.44

-0.51

Dividends

Dividend History

Viatris Inc. provided a 3.12% dividend yield over the last twelve months, with an annual payout of $0.48 per share. The company has been increasing its dividends for 4 consecutive years.


2.50%3.00%3.50%4.00%4.50%$0.00$0.10$0.20$0.30$0.40$0.5020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021
Dividend$0.48$0.48$0.48$0.48$0.48$0.33

Dividend yield

3.12%3.86%3.86%4.43%4.31%2.44%

Monthly Dividends

The table displays the monthly dividend distributions for Viatris Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.12$0.00$0.12$0.00$0.24
2025$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.48
2024$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.48
2023$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.48
2022$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.48
2021$0.11$0.00$0.00$0.11$0.00$0.00$0.11$0.00$0.33

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Viatris Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Viatris Inc. was 54.33%, occurring on Apr 10, 2025. Recovery took 208 trading sessions.

The current Viatris Inc. drawdown is 10.91%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-54.33%Apr 2025
4y 3mo10mo 5d
5y 1moJan 2021 - Feb 2026
2026 correction2026
-18.97%Mar 2026
1mo 16d1mo 8d
2mo 24dFeb 2026 - May 2026
2026 correction2026
-10.97%Jun 2026
1mo 11d
1mo 16dMay 2026 - now
2020 pullback2020
-7.40%Nov 2020
3d1mo 7d
1mo 10dNov 2020 - Dec 2020
2020 pullback2020
-0.92%Nov 2020
0s1d
1dNov 2020 - Nov 2020

Drawdown Indicators


VTRSBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-54.33%

-56.78%

+2.45%

Max Drawdown (1Y)

Largest decline over 1 year

-18.97%

-9.10%

-9.87%

Max Drawdown (3Y)

Largest decline over 3 years

-45.02%

-18.90%

-26.12%

Max Drawdown (5Y)

Largest decline over 5 years

-45.69%

-25.43%

-20.26%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-10.91%

-1.80%

-9.11%

Average Drawdown

Average peak-to-trough decline

-30.66%

-10.71%

-19.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.75%

2.03%

+4.72%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Viatris Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Viatris Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for VTRS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, VTRS has a P/S ratio of 1.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for VTRS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, VTRS has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with VTRS

Add Viatris Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with VTRS